Holen Sie sich die Stockscreener-App
5.67
4.42%
0.24
Handel nachbörslich:
5.55
-0.12
-2.12%
Schlusskurs vom Vortag:
$5.43
Offen:
$5.47
24-Stunden-Volumen:
54,737
Relative Volume:
0.05
Marktkapitalisierung:
$6.83M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+16.19%
1M Leistung:
-29.12%
6M Leistung:
-98.61%
1J Leistung:
-99.83%
1-Tages-Spanne:
$5.45
$5.71
1-Wochen-Bereich:
$4.85
$5.71
52-Wochen-Spanne:
$4.2701
$17,908.00
Cero Therapeutics Holdings Inc Stock (CERO) Company Profile
Firmenname
Cero Therapeutics Holdings Inc
Sektor
Branche
Telefon
650-407-2376
Adresse
201 HASKINS WAY, SOUTH SAN FRANCISCO
Vergleichen Sie CERO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CERO
Cero Therapeutics Holdings Inc
|
5.67 | 6.55M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.36 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.06 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.32 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Cero Therapeutics Holdings Inc Stock (CERO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-23 | Hochstufung | D. Boral Capital | Hold → Buy |
Cero Therapeutics Holdings Inc Aktie (CERO) Neueste Nachrichten
Risk Analysis: Should you avoid CERo Therapeutics Holdings Inc Equity Warrant stock right now2025 Sector Review & Daily Stock Trend Reports - خودرو بانک
Insider Sell: Will CERo Therapeutics Holdings Inc Equity Warrant outperform small cap indexes2025 Major Catalysts & Free Fast Entry Momentum Trade Alerts - خودرو بانک
Profit Review: Does Cass Information Systems Inc. have a competitive edgeStop Loss & Weekly High Conviction Ideas - خودرو بانک
Market Rankings: Will Paychex Inc. benefit from current market trendsSell Signal & Safe Entry Zone Identification - خودرو بانک
Analyst Calls: Whats CERo Therapeutics Holdings Incs historical return2025 Growth vs Value & Technical Confirmation Alerts - خودرو بانک
Aug Ideas: Is CERo Therapeutics Holdings Inc likely to announce a buybackGap Down & Daily Technical Forecast Reports - خودرو بانک
Block Trades: Can CERo Therapeutics Holdings Inc Equity Warrant outperform in the next rallyJuly 2025 Summary & Reliable Intraday Trade Alerts - خودرو بانک
Breakouts Watch: Is CERo Therapeutics Holdings Inc Equity Warrant benefiting from interest rate changesWeekly Stock Recap & Reliable Volume Spike Alerts - خودرو بانک
Bank Watch: Is CERo Therapeutics Holdings Inc exposed to currency risks2025 Key Highlights & AI Powered Market Entry Ideas - خودرو بانک
Chipmakers Recap: Can CERo Therapeutics Holdings Inc outperform in the next rally2025 Retail Activity & Stock Portfolio Risk Management - خودرو بانک
EV Market: What drives UVSP’s stock priceInsider Buying & Accurate Intraday Trading Signals - خودرو بانک
Can CERo Therapeutics Holdings Inc deliver alphaWeekly Profit Summary & Community Trade Idea Sharing Platform - خودرو بانک
Aug Closing: What are analysts price targets for CERo Therapeutics Holdings IncWeekly Trend Report & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
Aug Analyst Calls: Is CERo Therapeutics Holdings Inc.’s growth already priced inTrade Risk Summary & Weekly Market Pulse Alerts - خودرو بانک
Trade Recap: Can CERo Therapeutics Holdings Inc deliver consistent dividends2025 Market Outlook & Fast Moving Stock Trade Plans - خودرو بانک
Buyback Watch: Can CERo Therapeutics Holdings Inc be recession proof2025 Price Targets & Verified Stock Trade Ideas - خودرو بانک
CERo Therapeutics secures key patent protection for cancer therapy By Investing.com - Investing.com Australia
Is CERo Therapeutics Holdings Inc. likely to announce a buybackEarnings Recap Summary & Weekly Sector Rotation Insights - Lancaster City Council
Top 3 Health Care Stocks You'll Regret Missing In Q3 - Benzinga
CERo Therapeutics secures key patent protection for cancer therapy - Investing.com
CERo Therapeutics Receives Notice of Allowance from U.S. Patent and Trade Office on Composition of Matter and Method of Use for CER-1236 in Cancer with Expected Protection Through 2041 - The Manila Times
CERo Therapeutics Receives Notice of Allowance from U.S. - GlobeNewswire
Momentum Screeners Rank CERo Therapeutics Holdings Inc. Equity Warrant in Top 5 TodayFed Meeting & Weekly High Conviction Trade Ideas - beatles.ru
CERo Therapeutics Faces Nasdaq Delisting Risk - MSN
CERo Therapeutics Holdings Inc. Volume Confirms Breakout — Analysts BullishJuly 2025 Update & Community Verified Trade Alerts - beatles.ru
CERo Therapeutics Holdings Inc. Equity Warrant Stock Fails to Break Resistance Traders React2025 Technical Patterns & Free Low Drawdown Momentum Trade Ideas - beatles.ru
CERo Therapeutics administers second dose in AML clinical trial By Investing.com - Investing.com South Africa
Published on: 2025-09-08 20:17:23 - beatles.ru
CERo Therapeutics administers second dose in AML clinical trial - Investing.com
CERo Therapeutics Holdings Inc. Price Holds Above Key Fib Level2025 Market Sentiment & Risk Adjusted Buy/Sell Alerts - beatles.ru
CERo Therapeutics advances Phase 1 CER-1236 trial with dose intensification in AML - MarketScreener
CERo Therapeutics Announces Dose Intensification in Phase 1 Study of CER-1236 in Acute Myeloid Leukemia - GlobeNewswire
First-Ever TIM-4 Targeting Cell Therapy: CERo Therapeutics Advances AML Treatment with Doubled Dose Protocol - Stock Titan
Can CERo Therapeutics Holdings Inc. maintain its current growth rate2025 Momentum Check & Precise Entry and Exit Recommendations - beatles.ru
Is CERo Therapeutics Holdings Inc. being accumulated by smart moneyWeekly Profit Analysis & Weekly Consistent Profit Watchlists - خودرو بانک
Is CERo Therapeutics Holdings Inc. stock a good pick for beginnersMarket Growth Summary & High Accuracy Swing Entry Alerts - خودرو بانک
Published on: 2025-09-05 23:15:37 - خودرو بانک
What are CERo Therapeutics Holdings Inc. Equity Warrant’s growth leversJuly 2025 Reactions & Weekly High Potential Alerts - خودرو بانک
FDA grants fast track designation to CERo’s leukemia therapy By Investing.com - Investing.com Canada
What’s CERo Therapeutics Holdings Inc.’s historical returnWeekly Profit Summary & Entry Point Confirmation Alerts - خودرو بانک
Published on: 2025-09-06 00:07:46 - خودرو بانک
Energy Moves: Is CERo Therapeutics Holdings Inc. stock overvalued or fairly pricedTrade Performance Summary & Community Verified Trade Alerts - خودرو بانک
How to manage a losing position in CERo Therapeutics Holdings Inc.July 2025 Action & Long-Term Growth Stock Strategies - Newser
Historical volatility pattern of CERo Therapeutics Holdings Inc. visualized2025 Institutional Moves & Growth Focused Entry Point Reports - Newser
Will CERo Therapeutics Holdings Inc. bounce back from current support2025 Technical Patterns & Safe Entry Momentum Stock Tips - Newser
How to track smart money flows in CERo Therapeutics Holdings Inc. Equity Warrant2025 Support & Resistance & Momentum Based Trading Signals - Newser
Will CERo Therapeutics Holdings Inc. Equity Warrant outperform its industry peers2025 Technical Overview & Comprehensive Market Scan Insights - خودرو بانک
Published on: 2025-09-05 13:18:23 - Newser
CERo Therapeutics Gets Fast Track Designation For Experimental Cancer Drug, But Stock Tumbles – Here’s What Happened - Stocktwits
Is CERo Therapeutics Holdings Inc.’s growth already priced inMarket Growth Summary & Weekly Watchlist of Top Performers - خودرو بانک
CERo Therapeutics’ CER-1236: A High-Conviction Biotech Play with Accelerated Regulatory Pathways and Transformative AML Potential - AInvest
Finanzdaten der Cero Therapeutics Holdings Inc-Aktie (CERO)
Es liegen keine Finanzdaten für Cero Therapeutics Holdings Inc (CERO) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.77%
1.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):